Glycogenic hepatopathy
Glycogenic hepatopathy is a rare and underdiagnosed complication of Type 1 diabetes, characterized by the excessive accumulation of glycogen in the hepatocytes. It was first described in 1930 by Mauriac as a component of Mauriac syndrome, a rare pediatric syndrome associated with poorly controlled type 1 diabetes.
Etiology[edit | edit source]
The exact cause of glycogenic hepatopathy is not well understood. It is believed to be related to poor glycemic control in patients with type 1 diabetes. The condition is thought to result from the rapid fluctuation of blood glucose levels, leading to excessive glycogen storage in the hepatocytes.
Clinical Presentation[edit | edit source]
Patients with glycogenic hepatopathy typically present with hepatomegaly, elevated liver enzymes, and poorly controlled diabetes. The condition is often mistaken for nonalcoholic fatty liver disease (NAFLD), as the clinical presentation and laboratory findings can be similar. However, unlike NAFLD, glycogenic hepatopathy is reversible with improved glycemic control.
Diagnosis[edit | edit source]
The diagnosis of glycogenic hepatopathy is typically made through a combination of clinical history, laboratory findings, and liver biopsy. The liver biopsy will show swollen hepatocytes filled with glycogen, without the inflammation or fibrosis typically seen in NAFLD.
Treatment[edit | edit source]
The primary treatment for glycogenic hepatopathy is improved glycemic control. This can be achieved through a combination of diet, exercise, and medication. In severe cases, insulin therapy may be required. With improved glycemic control, the hepatomegaly and liver enzyme elevations typically resolve within weeks to months.
Prognosis[edit | edit source]
The prognosis for glycogenic hepatopathy is generally good, with most patients experiencing complete resolution of symptoms with improved glycemic control. However, if left untreated, the condition can lead to severe liver damage and potentially liver failure.
See Also[edit | edit source]
| Glycogenic hepatopathy Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
